Diagnostyka (FRA:7JS) Other Long-Term Liabilities: €11.8 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7JS Diagnostyka SA FRA:7JS
18 GF Score
Price €39.36
! 1 Warning Sign
View Full Analysis

What is Diagnostyka Other Long-Term Liabilities?

Diagnostyka FRA:7JS +2.13% 18 Other Long-Term Liabilities is €11.8 Mil as of Mar. 2026. GuruFocus rates FRA:7JS with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Diagnostyka's other long-term liabilities for the quarter that ended in Mar. 2026 was €11.8 Mil.

Diagnostyka's quarterly other long-term liabilities increased from Sep. 2025 (€16.9 Mil) to Dec. 2025 (€18.0 Mil) but then declined from Dec. 2025 (€18.0 Mil) to Mar. 2026 (€11.8 Mil).

Diagnostyka's annual other long-term liabilities increased from Dec. 2023 (€1.8 Mil) to Dec. 2024 (€12.6 Mil) and increased from Dec. 2024 (€12.6 Mil) to Dec. 2025 (€18.0 Mil).

Diagnostyka Other Long-Term Liabilities Related Terms

Diagnostyka Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Diagnostyka's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnostyka Other Long-Term Liabilities Chart

Diagnostyka Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
0.70 0.86 1.82 12.64 18.02

Diagnostyka Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.96 15.25 16.89 18.02 11.76
FRA:7JS
18GF Score
Diagnostyka SA FRA:7JS
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diagnostyka Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of €11.8 Mil mean?
Diagnostyka (FRA:7JS) has a Other Long-Term Liabilities of €11.8 Mil as of Mar. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Diagnostyka and its competitors.
Is Diagnostyka's Other Long-Term Liabilities too high?
Diagnostyka's current Other Long-Term Liabilities is €11.8 Mil. Overall, Diagnostyka has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Diagnostyka's Other Long-Term Liabilities compare to TMO and DHR?
Diagnostyka's Other Long-Term Liabilities of €11.8 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Diagnostics & Research company?
A good Other Long-Term Liabilities depends on the Medical Diagnostics & Research industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Diagnostyka and its competitors. Diagnostyka's current Other Long-Term Liabilities is €11.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostyka stock overvalued right now?
Diagnostyka (FRA:7JS) has a current Other Long-Term Liabilities of €11.8 Mil. The current Other Long-Term Liabilities is €11.8 Mil. Diagnostyka's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Diagnostyka (FRA:7JS), the current Other Long-Term Liabilities is €11.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diagnostyka Business Description

Other Exchanges DIA:Poland
Address Ul. Prof. Michala Zyczkowskiego 16, Krakow, POL, 31-864
Diagnostyka SA is engaged in providing laboratory diagnostics services in Poland. The company offers comprehensive laboratory services from collecting biological material, through testing, to providing results online.
18GF Score

Get the complete analysis for FRA:7JS

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€39.36
Price